Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433869
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-04-23
Brief Title:
The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis FactorrmhTNF-NC in the Treatment of Malignant Ascites
Sponsor:
Organization:
Sun Yat-sen University